seen from Tunisia
seen from Germany
seen from United States
seen from Kazakhstan
seen from United States
seen from Sweden
seen from India
seen from Philippines
seen from Germany
seen from United Kingdom
seen from United States
seen from Ukraine
seen from Uzbekistan
seen from China
seen from Réunion
seen from United States
seen from Türkiye
seen from United States
seen from Netherlands
seen from Türkiye
BRIEF-Blueprint Medicines announces new data from ongoing phase 1 clinical trial of BLU-285 Nov 10 (Reuters) - Blueprint Medicines Corp * Blueprint Medicines announces new data from ongoing phase 1 clinical trial of BLU-285 in patients with advanced gastrointestinal stromal tumors showing strengthened clinical activity across spectrum of kit and pdgfrα genotypes…
